ATE403679T1 - Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum - Google Patents

Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum

Info

Publication number
ATE403679T1
ATE403679T1 AT03723513T AT03723513T ATE403679T1 AT E403679 T1 ATE403679 T1 AT E403679T1 AT 03723513 T AT03723513 T AT 03723513T AT 03723513 T AT03723513 T AT 03723513T AT E403679 T1 ATE403679 T1 AT E403679T1
Authority
AT
Austria
Prior art keywords
fibrinogen
fibrin
properties
lmw
hmw
Prior art date
Application number
AT03723513T
Other languages
English (en)
Inventor
Maat Monica De
Pieter Koolwijk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE403679T1 publication Critical patent/ATE403679T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03723513T 2002-04-18 2003-04-07 Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum ATE403679T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1020426A NL1020426C2 (nl) 2002-04-18 2002-04-18 Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.

Publications (1)

Publication Number Publication Date
ATE403679T1 true ATE403679T1 (de) 2008-08-15

Family

ID=29244993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03723513T ATE403679T1 (de) 2002-04-18 2003-04-07 Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum

Country Status (10)

Country Link
US (2) US7867519B2 (de)
EP (1) EP1495051B1 (de)
JP (3) JP5083928B2 (de)
AT (1) ATE403679T1 (de)
AU (1) AU2003230455A1 (de)
CA (1) CA2482893C (de)
DE (1) DE60322687D1 (de)
DK (1) DK1495051T3 (de)
NL (1) NL1020426C2 (de)
WO (1) WO2003087160A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1592373B1 (de) 2003-01-30 2013-04-24 ProChon Biotech Ltd. Gefriergetrocknete fibrinmatrizen und herstellungsverfahren dafür
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP2106263B1 (de) 2007-01-04 2016-12-21 Hepacore Ltd. Wasserlösliche und reaktive derivate von carboxy-polysacchariden und fibrinogen-konjugate daraus
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
CA2717725A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
CN102089322B (zh) 2008-07-09 2015-09-23 普罗菲布瑞克斯公司 重组纤维蛋白原
BR112012016633A2 (pt) * 2010-01-08 2016-04-19 Profibrix Bv composição farmacêutica em pó seco e método de tratamento de ferida.
ES2524886T3 (es) * 2010-01-08 2014-12-15 Profibrix Bv Preparados de fibrinógeno enriquecidos en fibrinógeno con una cadena alfa extendida
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0564502B1 (de) * 1990-11-27 2002-01-30 The American National Red Cross Gewebeabdeckung und wachstumsfaktor enthaltende verbindungen zur förderung beschleunigter wundheilung
WO1995029686A1 (en) * 1994-05-02 1995-11-09 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
EP0804257B1 (de) * 1995-01-16 2003-07-09 Baxter International Inc. Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
AU8336098A (en) * 1997-06-05 1998-12-21 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
AU4351000A (en) * 1999-04-15 2000-11-02 Research Foundation Of State University Of New York, The Cellular matrix system and use thereof
US6613325B1 (en) * 1999-06-01 2003-09-02 Bristol-Myers Squibb Company Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
JP5395726B2 (ja) 2014-01-22
US20050181972A1 (en) 2005-08-18
WO2003087160A1 (en) 2003-10-23
US7867519B2 (en) 2011-01-11
EP1495051A1 (de) 2005-01-12
AU2003230455A1 (en) 2003-10-27
DE60322687D1 (de) 2008-09-18
EP1495051B1 (de) 2008-08-06
JP2005538045A (ja) 2005-12-15
DK1495051T3 (da) 2008-11-10
NL1020426C2 (nl) 2003-10-21
CA2482893C (en) 2014-08-12
CA2482893A1 (en) 2003-10-23
JP5248547B2 (ja) 2013-07-31
JP2010195805A (ja) 2010-09-09
JP5083928B2 (ja) 2012-11-28
JP2010246543A (ja) 2010-11-04
US20110071083A1 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
DE60322687D1 (de) Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum
ATE200630T1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
DK0625056T3 (da) Kompositmembraner til reguleret regenerering af væv
DE3880318D1 (de) Polypeptide mit kollagen typ iv aktivitaet.
DE69433920D1 (de) Supplementierte verdichtungsmittel für gewebe, methoden für ihre herstellung und ihre verwendung
ATE262356T1 (de) Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement
DK0590015T3 (da) Sammensætning til vævsbehandling omfattende fibrin eller fibrinogen og bionedbrydelig og bioforligelig polymer
AR040299A1 (es) Vendaje hemostatico para heridas y metodo para obtenerlo
DK1545565T3 (da) Sammensætninger, som indeholder mitotisk inaktiverede allogene fibroblaster og keratinocyter til anvendelse i regenerering af væv
NO20002357L (no) Fibrin-tetningsmidler eller -ad-hesiver inneholdende et hyaluronsyrederivat-materiale
IS8909A (is) Rauðkornavaki til örvunar á innanþekju forverafrumum.
DK1085917T3 (da) Biomaterialer indeholdende hyaluronsyrederivater i form af tredimensionale strukturer, som er frie for cellulære komponenter eller produkter deraf, til in vivo-regenerering af vævsceller
CA2097063A1 (en) Tissue sealant and growth factor containing compositions that promote accelerated wound healing
EP0390481A3 (de) Chirurgische Heftfolie
BR0008787A (pt) Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
DE69913543D1 (de) Dermales gerüst auf der grundlage eines neutralisierten chitosan-schwammes oder eines neutralsierten gemischten chitosan-kollagen-schwammes
DK1715900T3 (da) Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
DE3877765D1 (de) Polypeptide mit einer laminin-wirksamkeit.
DE60222543D1 (de) Fibrin enthaltende langgestreckte biopolymerstruktur
DE69820254D1 (de) Dermales hüllgewebe in der wundheilung
ATE227995T1 (de) Verwendung von pseudopterosin zur förderung der wundheilung
DE69328100D1 (de) Biodegradierbare führungskanäle zur verwendung als chirurgische hilfsmittel in gewebewiederherstellung
NO773189L (no) Kirurgisk sutur, samt fremgangsmaate ved lukking av saar i levende vev
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung
Pietramaggiori et al. Skin grafting and dermal substitute placement

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1495051

Country of ref document: EP